1. Which of the following is considered a probiotic?
A. Lactulose
B. Saccharomyces boulardii
C. Inulin
D. Oligofructose
2. Which of the following is NOT a method of altering the intestinal microflora?
A. Administration of antibiotics
B. Administration of prebiotics
C. Fecal transplantation
D. Administration of statins
3. Which of the following statements is FALSE?
A. In the name Bifidobacterium lactis DN-1773 010, Bifidobacterium denotes the genus
B. 1.6% of all American adults reported using probiotics in 2012, which was a 4-fold increase from 2007
C. In the name Bifidobacterium lactis DN-1773 010, lactis designates the strain
D. There is no generic equivalency between or among probiotic products
4. Which of the following statements regarding probiotics and antibiotic-associated diarrhea is TRUE?
A. Clear evidence describes the probiotic associated with greatest efficacy
B. VSL#3 might reduce the incidence of antibiotic-associated diarrhea
C. Lactobacillus may reduce the duration of diarrhea by 32 hours
D. VSL#3 was dosed 3 times daily in a clinical trial of its efficacy
5. If a patient is interested in trying probiotics for preventing Clostridium difficile -associated diarrhea, which product could you recommend that has preliminary evidence of effectiveness?
A. Florastor (Saccharomyces boulardii )
B. Activia yogurt (Bifidobacterium lactis DN-173 010)
C. RepHresh Pro-B (Lactobacillus rhamnosus GR-1 or Lactobacillus reuteri RC-1461)
D. Mutaflor (Escherichia coli Nissle 1917)
6. Which of the following properties of a probiotic are important for its effectiveness?
A. High bacterial count
B. Ability to withstand the pH in the stomach
C. Tolerant to bile acids
D. All of the above
7. Which of the following should be included in patient counseling regarding probiotics?
A. The concept that probiotics are considered “good bacteria”
B. Proper storage of the probiotic (e.g., refrigeration requirements)
C. Appropriate timing of probiotic administration in relation to other medications
D. All of the above
8. A probiotic CANNOT be classified into which of the following categories?
A. Injectable
B. Medical food
C. Drug
D. Food
9. ____________ is intended for enteral use in the “dietary management of a disease or condition for which distinctive nutritional requirements have been established by medical evaluation” and is formulated to be administered “under the supervision of a physician.”
A. Food
B. Medical food
C. Dietary supplement
D. Drug
10. Which of the following statements is FALSE?
A. Medical foods should be designated with the “Rx only” symbol
B. VSL#3 is a probiotic that is considered a medical food
C. The United States Food and Drug Administration does not require a prescription for VSL#3
D. VSL#3 requires a prescription to ensure patient adherence and adequate follow-up
Evaluation Questions
11. To what extent did the program meet objective #1?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
12. To what extent did the program meet objective #2?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
13. To what extent did the program meet objective #3?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
14. To what extent did the program meet objective #4?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
15. To what extent did the program meet objective #5?
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
16. Rate the effectiveness of how well the program related to your educational needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
17. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
18. Rate the quality of the faculty:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
19. Rate the effectiveness and the overall usefulness of the material presented:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
20. Rate the appropriateness of the examination for this activity:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
21. Rate the effectiveness of how well the activity related to your practice needs:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
22. Rate the effectiveness of how well the activity will help you improve patient care:
A. Excellent
B. Very Good
C. Good
D. Fair
E. Poor
23. Will the information presented cause you to change your practice?
A. Yes
B. No
24. Are you committed to making these changes?
A. Yes
B. No
25. As a result of this activity, did you learn something new?
A. Yes
B. No
26. What is your practice setting or area of practice?
A. Community Pharmacy/Independent
B. Community Pharmacy/Chain
C. Hospital/Health Systems
D. Administrative/Pharmacy Director
E. Critical Care Pharmacy
F. Long-term Care
G. Managed Care/PBM
H. Oncology
I. Specialty Pharmacy
J. Industry/Manufacturing
27. How many years have you been in practice?
A. <5
B. 5 – 10
C. 11 – 20
D. >20
